DocMorris
DocMorris N.V. is a publicly listed European e-pharmacy platform serving 11 million active customers across Germany, Netherlands, France, Austria, and Belgium with prescription medications, OTC products, and digital health services.
- Company typePublic
- Founded2000
- HeadquartersFrauenfeld, Switzerland
- Headcount501–1,000
- GTM typeB2C
- OfferingServices
What DocMorris does
DocMorris N.V. is a publicly listed European e-pharmacy platform operating across five markets (Germany, Netherlands, France, Austria, Belgium) and serving approximately 11 million active customers. The company runs a direct-to-consumer model that combines prescription medication fulfillment, over-the-counter (OTC) product sales, and an expanding portfolio of digital health services, with e-prescription processing as a core technical capability of the platform. Underlying technology includes automated fulfillment warehouses, e-prescription integrations, an AI assistant (DocMorris Assistent), third-party AI integrations via Infermedica and Google Gemini, and a marketplace layer that hosts third-party pharma and consumer health products.
The business model is multi-revenue-stream: transaction-based pricing on prescription and OTC products, subscription revenue from the Rezept-Abo recurring prescription service, commissions on third-party marketplace offerings, and revenue from insurance and digital health service partners. Commercial tactics include free e-prescription co-payment coverage (zuzahlungsfrei), free shipping above €22.90 or on prescription orders, and a Rezept-Bonus of at least €2.50 per medication to drive repeat prescription migration. Customer segments range from individual chronic-medication consumers and health-conscious preventive care buyers to corporate wellness and insurance partners; the Rezept-Abo subscription and German e-prescription co-payment program are the primary retention mechanisms.
DocMorris is listed on the SIX Swiss Exchange under ticker DOCN, is incorporated in the Netherlands (Heerlen), and operates under Walter Hess as CEO. The company previously operated as Zur Rose Group and completed its rebranding to DocMorris by end of 2024. In 2025, DocMorris generated approximately CHF 1.19 billion in external revenue (+11.1% YoY), with German prescription drug sales of CHF 234.8 million (+33.2% YoY) and digital services revenue growth of approximately 110% YoY. The company reported adjusted EBITDA of CHF -50 million in 2025, with guidance for EBITDA of CHF -10 to -25 million in 2026 and a target of free cash flow break-even in 2027.
DocMorris firmographics
Firmographics- Name
- DocMorris
- Legal name
- DocMorris N.V.
- Website
- https://docmorris.de
- Company type
- Public
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- DocMorris N.V. is a publicly listed European e-pharmacy platform serving 11 million active customers across Germany, Netherlands, France, Austria, and Belgium with prescription medications, OTC products, and digital health services.
- Ownership category
- akta.pro rank
DocMorris industry classification
Industry- Product category
- Online Pharmacy
- NAICS
- Pharmacies and Drug Retailers (456110), Pharmacies and Drug Retailers (45611)
- SIC
- Retail-Drug Stores And Proprietary Stores (5912), Services-Health Services (8000)
- akta.pro primary industry
- Mail-Order & Home Delivery Pharmacies (HLAFALAD)
- akta.pro secondary industries
- Telepharmacy & Prescription Fulfillment Marketplaces (HLALALAF), Pharmacy-Integrated Virtual Care & ePrescribing (Employer Benefit) (HLALADAH), Pharmacy & Health Essentials Delivery (CRAFAFAI)
Keywords
Where DocMorris is headquartered
LocationHeadquarters
- HQ city
- Frauenfeld
- HQ country
- Switzerland
- HQ region
- Europe
Offices2 records
Markets served
DocMorris business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Operations, Personnel, Marketing or Sales, Supply Chain, Technology or R&D, Infrastructure
Revenue model
- Prescription Medication Sales: DocMorris processes and delivers prescription medications directly to consumers, integrated with national health systems and insurance companies. Revenue from prescription drugs in Germany grew 33.2% year-over-year to CHF 234.8 million in 2025.
- Over-the-Counter (OTC) Medications and Health Products: Sale of OTC medications, beauty and care products, vitamins, nutritional supplements, and medical supplies through the e-pharmacy platform. The platform offers a wide range of OTC products with competitive pricing.
- Digital Health Services: DocMorris generates revenue from digital health services including telemedicine consultations, online doctor consultations, and AI-powered health assessments. Digital services revenue more than doubled with 110% growth year-over-year.
- Healthcare Provider and Insurance Integrations: Revenue streams beyond direct-to-consumer sales through integrations with healthcare providers, insurance companies, and corporate wellness programs, including chronic-care program management and fulfillment services.
- Marketplace and Third-Party Seller Commission: DocMorris operates a marketplace where third-party sellers offer products, with the company earning commissions on sales. Note: Marketplace orders have different shipping costs.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Transaction based/ take rate | Pay-as-you-go | Standard OTC and prescription order pricing with free shipping above €22.90 or on prescription orders |
| Subscription | Monthly | Rezept-Abo (Prescription Subscription) for recurring medications |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
DocMorris product offering
Product offeringCore offering
DocMorris operates Europe's largest e-pharmacy platform, dispensing prescription and over-the-counter medications, OTC health products, beauty/dermocosmetics items, vitamins, and pet care supplies directly to consumers across Germany, Netherlands, France, Austria, and Belgium. The platform integrates e-prescription processing, telepharmacy consultations, telemedicine, AI-powered symptom analysis, and a subscription-based recurring prescription service, with home delivery and pharmacist advisory support.
Product overview
DocMorris operates as Europe's largest e-pharmacy platform offering a unified digital health ecosystem. The core platform centers on E-Rezept (e-prescription) services and Online-Arzt (telemedicine) consultations, supported by the DocMorris App for mobile access. AI capabilities are delivered through the DocMorris Assistent powered by Google Gemini models, integrating symptom analysis (Infermedica) and metabolic health assessments (Hello Inside). The platform complements prescription medications with OTC products, beauty & dermocosmetics (including private labels PYUR and SPLMNT LAB), vitamins, and pet health supplies. Additional services include pharmaceutical consultation (phone, video, in-app chat), drug interaction checks, medication profiles, skin health checks, and obesity treatment programs. The ecosystem integrates with insurance companies, healthcare providers, and corporate wellness programs, serving 11 million active customers across Germany, Netherlands, France, Austria, and Belgium.
Differentiator
Problem solved
Functional benefit
Brands
- PYUR: Dermocosmetics brand for weather-related skin stress.
- SPLMNT LAB
- DocMorris Eigenmarke
Products and services
- E-Rezept (E-Prescription Service) Digital prescription fulfillment service allowing customers to redeem electronic prescriptions online with home delivery and waived co-payments.
- Online-Arzt (Online Doctor / Telemedicine) Telemedicine service enabling patients to consult licensed doctors online for prescription requests and health assessments.
- DocMorris App Mobile app for iOS and Android enabling e-prescription scanning, order management, personalized recommendations, and access to DocMorris health services.
- DocMorris Assistent (AI Assistant) AI-powered health companion providing product search, quick consultation, drug interaction checks, and health checks in one place, available 24/7.
- Rezept-Abo (Prescription Subscription) Subscription service managing recurring prescriptions automatically, ensuring patients receive continuous medication supply without manual reordering.
- Pharmazeutische Beratung (Pharmaceutical Consultation) Professional pharmacy advisory service offering telephone consultation, video-live chat, drug interaction checks, and medication profile reviews by licensed pharmacists.
- Haut-Check (Skin Check) Online skin assessment tool enabling users to evaluate skin changes and receive health guidance through the DocMorris platform.
- Adipositas Behandlung (Obesity Treatment Program) Obesity treatment program offering modern therapies, GLP-1 medication options, patient guidance, and integrated digital healthcare services.
- PYUR (Private Label Dermocosmetics) DocMorris private label dermocosmetics brand offering products targeting weather-related skin stress.
- SPLMNT LAB (Private Label Supplements) DocMorris private label longevity nutrition brand offering systematic dietary supplements including memory and concentration support products.
- DocMorris Eigenmarke (DocMorris Private Label Health Products) DocMorris private label health product line offering proven quality supplements and health products at fair prices.
Quantifiable outcome
- 11 million active customers
- +5 more outcomes
Companies that use DocMorris
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles3 records
DocMorris technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration10 records
AI capability8 records
Feature5 records
DocMorris partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core.
- Google (Google Cloud)coreDocMorris partnered with Google to develop an AI-first digital health platform using Google Gemini AI models, Google Cloud infrastructure, and Google for Health tools. The collaboration aims to enhance patient services and internal efficiency across European markets with emphasis on digital sovereignty and data protection, focusing on a personal health guide and conversational AI for DocMorris's 11 million active customers.
- InfermedicacoreDocMorris expanded its healthcare platform by integrating AI-powered symptom analysis from Infermedica to enhance its telemedicine and pharmacy services. The collaboration aims to streamline patient assessments and improve access to medical care through an AI-supported ecosystem. Beta rollout began in October 2025.
- Hello InsidecoreHello Inside, a metabolic health and longevity platform, partnered with DocMorris to integrate metabolic health checks and personalised wellness programs into DocMorris's digital health platform, creating a new 'Care' section accessible to 11 million active customers. The integration provides a five-minute metabolic health assessment evaluating nutrition, movement, sleep, mindfulness, and body vitals, along with science-based educational courses covering glucose management, hormonal balance, and menopause support.
- Healthcare Providers and Insurance CompaniescoreDocMorris integrates with healthcare providers, insurance companies, and corporate wellness programs to create revenue streams beyond direct-to-consumer sales. The platform processes medication orders with fulfillment warehouses, integrating with national health systems and insurance for prescription drug reimbursement.
- National Health Systems (Germany)coreDocMorris integrates with German national health systems to process e-prescriptions, enabling direct billing and reimbursement for statutory health insurance patients. The company plans to expand its e-prescription service from its Emmen location near the German border.
Scale indicators11 records
Recent moves6 records
Expansion highlights5 records
DocMorris competitors and assessment
Company assessmentBroad incumbents
- Cigna / Express Scripts: US-based managed care and pharmacy benefit manager with a large mail-order pharmacy operation. Compares to DocMorris as a scaled mail-order/ home-delivery pharmacy serving insured patients, though geographically and structurally different.
- Phoenix Group: European pharmaceutical wholesale and pharmacy retail group operating across multiple EU markets. Comparable multi-country European pharmaceutical distribution footprint to DocMorris's geographic reach, though focused on wholesale rather than D2C e-commerce.
Direct peers
- Medikamente-per-Klick: German online mail-order pharmacy offering OTC and prescription delivery. Similar D2C e-pharmacy model focused on German consumers, comparable assortment and delivery promise to DocMorris.
- Apotal: German online pharmacy operating mail-order prescription and OTC fulfillment. Overlapping target customer base, product categories, and e-pharmacy delivery model with DocMorris.
- SANICARE Versandapotheke: German mail-order pharmacy delivering prescription and OTC medications nationwide. Direct competitor in the German e-pharmacy space with comparable product breadth and prescription fulfillment capabilities.
- Aponeo: Berlin-based German online pharmacy offering OTC, prescription, and pharmacy-only products with home delivery. Comparable in product scope and German consumer target market to DocMorris.
- Shop Apotheke Europe (Redcare Pharmacy): Largest direct European competitor in online pharmacy, operating across multiple EU markets with prescription and OTC fulfillment plus digital health services. Closely comparable business model, customer base, and regulatory footprint to DocMorris.
Regional players
- Pharmacy2U: UK's largest online pharmacy providing NHS prescription delivery and OTC products. Comparable mail-order pharmacy model but focused on the UK market rather than Continental Europe.
Emerging players
- Doctolib: Leading European telehealth and online appointment-booking platform with strong German and French presence. Overlaps with DocMorris's Online-Arzt telemedicine service and digital health roadmap but lacks pharmacy fulfillment.
- Zava: European online doctor and digital health platform offering remote consultations and prescription delivery across multiple EU markets. Comparable telemedicine + e-prescription journey to DocMorris's Online-Arzt integration.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
DocMorris social profiles
Digital presenceDocMorris compliance and trust
Trust signalCompliance3 records
DocMorris financial estimates
Financial estimateRevenue estimate
Valuation estimate
DocMorris leadership team
Management profileNumber of profiles
Profiles9 records
DocMorris funding detail
Funding detailFunding overview
Funding rounds2 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DocMorris M&A and investment
M&A and investmentM&A1 record
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DocMorris
What does DocMorris do?
DocMorris operates Europe's largest e-pharmacy platform, dispensing prescription and over-the-counter medications, OTC health products, beauty/dermocosmetics items, vitamins, and pet care supplies directly to consumers across Germany, Netherlands, France, Austria, and Belgium. The platform integrates e-prescription processing, telepharmacy consultations, telemedicine, AI-powered symptom analysis, and a subscription-based recurring prescription service, with home delivery and pharmacist advisory support.
Is DocMorris a public or private company?
DocMorris is a public company. It is classified as public and is currently operating.
When was DocMorris founded?
DocMorris was founded in 2000. It employs 501 to 1,000 people.
Where is DocMorris based?
DocMorris is headquartered in Frauenfeld, Switzerland, in the Europe region.
How does DocMorris make money?
Five revenue lines are on record. Prescription Medication Sales are the primary driver. The others are over-the-Counter (OTC) Medications and Health Products, digital Health Services, healthcare Provider and Insurance Integrations and marketplace and Third-Party Seller Commission.
Who are DocMorris's main competitors?
Broad incumbents on record are Cigna / Express Scripts and Phoenix Group. Direct peers are Medikamente-per-Klick, Apotal, SANICARE Versandapotheke, Aponeo and Shop Apotheke Europe (Redcare Pharmacy). Pharmacy2U is listed as a regional player. Emerging players are Doctolib and Zava.
Does DocMorris have an API?
No public API is recorded for DocMorris.
What industry is DocMorris in?
DocMorris's product category is Online Pharmacy. Its primary akta.pro industry code is HLAFALAD, Mail-Order & Home Delivery Pharmacies, with a secondary code of HLALALAF, Telepharmacy & Prescription Fulfillment Marketplaces. Its NAICS code is 456110 and its SIC code is 5912.